Steve Scala Analyst PerformanceSenior Research Analyst at TD CowenSteve Scala is a stock analyst at TD Cowen focused in the medical sector, covering 14 publicly traded companies. Over the past year, Steve Scala has issued 5 stock ratings, including buy and hold recommendations. While full access to Steve Scala's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Steve Scala's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings48 Last 11 YearsBuy Recommendations74.47% 35 Buy RatingsCompanies Covered14 Unique Companies Ratings Distribution47RatingsDistribution of strong buy, buy, hold, and sell ratings by Steve Scala.RatingPercentageCount Strong Buy0.0%0 ratings Buy74.5%35 ratings Hold25.5%11 ratings Sell0.0%0 ratingsOut of 47 total stock ratings issued by Steve Scala at TD Cowen, the majority (74.5%) have been Buy recommendations, followed by 25.5% Hold.Best & Worst CallsBest Call000.0%ZTSAug 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ABBVJul 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE78.6% of companies on NYSE11 companiesNASDAQ14.3% of companies on NASDAQ2 companiesOTCMKTS7.1% of companies on OTCMKTS1 companySteve Scala, an analyst at TD Cowen, currently covers 14 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical13 companies92.9%Manufacturing1 company7.1%Steve Scala of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageLARGE CAP PHARMA8 companies57.1%MED - BIOMED/GENE3 companies21.4%MED - DRUGS1 company7.1%MED - OUTP/HM CRE1 company7.1%Miscellaneous1 company7.1% About Steve ScalaSteve Scala is a senior research analyst with more than 30 years of experience following the pharmaceutical industry, including large-, mid- and small-cap companies. Prior to joining TD Cowen, Mr. Scala was a pharmacist at Tufts Medical Center in Boston. He received a BS in pharmacy from the University of Connecticut, an MS in pharmacy from Ohio State University, and an MBA from Bentley College. He is a CFA charterholder.Follow on LinkedIn Steve Scala's Ratings History at TD Cowen Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsZTSZoetis6/30/2026Lower Price Target$72.32$104.00Buy$0.0000.00% ROIELANElanco Animal Health6/18/2026Boost Price Target$24.23$32.00Buy$0.0000.00% ROIRPRXRoyalty Pharma2/27/2026Reiterated Rating$46.20Buy$0.0000.00% ROIMRKMerck & Co., Inc.1/20/2026Boost Price Target$108.76$120.00Hold$0.0000.00% ROIRPRXRoyalty Pharma12/11/2025Boost Price Target$38.21$45.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupEvercoreRoth MkmBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupDeutsche Bank AktiengesellschaftRaymond James FinancialBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
